glp 1 agonist clinical trials The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine GLP-1 receptor agonists show promise
Description
The other half began taking a DPP-4 inhibitor comparator "gliptins," a different class of diabetes medications, the study noted
since then, states have been redetermining Medicaid enrollment every 12 months
[DOI] [PMC free article] [PubMed] [Google Scholar] 108.Regmi A, Aihara E, Christe ME, Varga G, Beyer TP, et al
doi: 10.1007/s00125-006-0510-2
